TSX Penny Stocks Spotlight Delota And Two Others

In This Article:

As the Canadian market experiences a period of stabilized yields and moderated inflation, investors are keeping a close eye on potential opportunities within the TSX. Penny stocks, often associated with smaller or newer companies, continue to intrigue investors due to their mix of affordability and growth potential when backed by solid financials. In this context, we'll explore several standout penny stocks that exhibit strong financial foundations and could offer promising prospects for those seeking under-the-radar investments.

Top 10 Penny Stocks In Canada

Name

Share Price

Market Cap

Financial Health Rating

Alvopetro Energy (TSXV:ALV)

CA$4.78

CA$175.48M

★★★★★★

Mandalay Resources (TSX:MND)

CA$4.73

CA$453.58M

★★★★★★

Findev (TSXV:FDI)

CA$0.52

CA$14.04M

★★★★★★

PetroTal (TSX:TAL)

CA$0.70

CA$641.48M

★★★★★★

NamSys (TSXV:CTZ)

CA$1.09

CA$31.16M

★★★★★★

East West Petroleum (TSXV:EW)

CA$0.045

CA$4.07M

★★★★★★

Orezone Gold (TSX:ORE)

CA$0.82

CA$379.19M

★★★★★☆

New Gold (TSX:NGD)

CA$3.89

CA$3.2B

★★★★★☆

Foraco International (TSX:FAR)

CA$1.92

CA$192.45M

★★★★★☆

DIRTT Environmental Solutions (TSX:DRT)

CA$1.04

CA$210.81M

★★★★☆☆

Click here to see the full list of 940 stocks from our TSX Penny Stocks screener.

Here's a peek at a few of the choices from the screener.

Delota

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Delota Corp. operates in Canada, focusing on the retail of various cannabis products, with a market cap of CA$2.77 million.

Operations: The company generates CA$40.08 million in revenue from its specialty retail segment.

Market Cap: CA$2.77M

Delota Corp. has expanded its retail footprint to 32 locations in Ontario, with plans for further growth into Western Canada. Despite a volatile share price and increased debt-to-equity ratio, Delota reported CA$10.29 million in third-quarter sales, up from the previous year, and achieved a net income of CA$0.47 million compared to a loss previously. The company benefits from an experienced board and management team, with sufficient cash runway for over three years due to positive free cash flow growth. However, short-term liabilities exceed assets, posing potential liquidity challenges amidst its expansion efforts.

CNSX:NIC Debt to Equity History and Analysis as at Feb 2025
CNSX:NIC Debt to Equity History and Analysis as at Feb 2025

Quipt Home Medical

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Quipt Home Medical Corp. operates in the United States through its subsidiaries, providing durable and home medical equipment and supplies, with a market cap of CA$161.59 million.